We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
(+6.1%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20
Top Buys
| 1 |
Eli Lilly
LLY
|
+$23M |
| 2 |
Novavax
NVAX
|
+$18.4M |
| 3 |
iQIYI
IQ
|
+$17.4M |
| 4 |
Cboe Global Markets
CBOE
|
+$17M |
| 5 |
Netflix
NFLX
|
+$16.8M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$27.7M |
| 2 |
Roku
ROKU
|
+$20.6M |
| 3 |
Simon Property Group
SPG
|
+$16.5M |
| 4 |
NIO
NIO
|
+$15.7M |
| 5 |
Moderna
MRNA
|
+$13.5M |
Sector Composition
| 1 | Consumer Staples | 21.66% |
| 2 | Healthcare | 21% |
| 3 | Consumer Discretionary | 11.38% |
| 4 | Communication Services | 9.41% |
| 5 | Materials | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
JPMorgan Chase
JPM
$907B
| $275K | 0.01% |
1,765
+426
| +32% | +$66.9K |
|
177
Crown Castle
CCI
$34.6B
| $271K | 0.01% |
1,391
-199
| -13% | -$37.3K |
|
178
FedEx
FDX
$74.7B
| $258K | 0.01% |
865
| – | – |
|
179
Advanced Micro Devices
AMD
$808B
| $256K | 0.01% |
2,728
-1,525
| -36% | -$123K |
|
180
General Motors
GM
$68.6B
| $254K | 0.01% |
4,297
| – | – |
|
181
TJX Companies
TJX
$171B
| $254K | 0.01% |
3,762
| – | – |
|
182
Las Vegas Sands
LVS
$30.1B
| $247K | 0.01% |
4,680
-170,627
| -97% | -$9.85M |
|
|
MRSH
183
Marsh
MRSH
$87.8B
| $244K | 0.01% |
1,734
| – | – |
|
184
Equinix
EQIX
$101B
| $242K | 0.01% |
302
| – | – |
|
185
Deere & Co
DE
$161B
| $240K | 0.01% |
680
+297
| +78% | +$108K |
|
186
Colgate-Palmolive
CL
$74.4B
| $238K | 0.01% |
2,930
| – | – |
|
187
Illumina
ILMN
$28.2B
| $236K | 0.01% |
513
| – | – |
|
188
US Bancorp
USB
$98.4B
| $232K | 0.01% |
4,065
-716
| -15% | -$42K |
|
189
Estee Lauder
EL
$29.7B
| $226K | 0.01% |
710
| – | – |
|
190
Bright Horizons
BFAM
$4.03B
| $224K | 0.01% |
1,526
+381
| +33% | +$57K |
|
191
Truist Financial
TFC
$65.4B
| $223K | 0.01% |
4,023
-734
| -15% | -$43.1K |
|
192
Datadog
DDOG
$92.1B
| $222K | 0.01% |
2,129
-380
| -15% | -$34.3K |
|
193
Edwards Lifesciences
EW
$49.4B
| $219K | 0.01% |
2,116
| – | – |
|
194
Intercontinental Exchange
ICE
$79B
| $219K | 0.01% |
1,842
| – | – |
|
195
Sherwin-Williams
SHW
$81.7B
| $218K | 0.01% |
801
| – | – |
|
196
BILL Holdings
BILL
$4.45B
| $217K | 0.01% |
1,185
+227
| +24% | +$35.6K |
|
197
Mercado Libre
MELI
$92B
| $213K | 0.01% |
137
-26
| -16% | -$38.2K |
|
198
Dominion Energy
D
$62.5B
| $211K | 0.01% |
2,872
| – | – |
|
199
Boston Scientific
BSX
$65.4B
| $203K | 0.01% |
4,759
+2,038
| +75% | +$85.7K |
|
200
Emerson Electric
EMR
$78.2B
| $203K | 0.01% |
2,109
| – | – |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q2 2021 Portfolio in Review
As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
- TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
- TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
- TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
- TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
- TOBAM opened 26 new positions and closed 20 in Q2 2021.
- TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.
Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.